On Invalid Date, Vincerx Pharma (NASDAQ: VINC) reported Q3 2023 earnings per share (EPS) of -$0.46, up 42.5% year over year. Total Vincerx Pharma earnings for the quarter were -$9.72 million. In the same quarter last year, Vincerx Pharma's earnings per share (EPS) was -$0.80.
As of Q1 2024, Vincerx Pharma's earnings has grown year over year. Vincerx Pharma's earnings in the past year totalled -$48.85 million.
What is VINC's earnings date?
Vincerx Pharma's earnings date is Invalid Date. Add VINC to your watchlist to be reminded of VINC's next earnings announcement.
What was VINC's revenue last quarter?
On Invalid Date, Vincerx Pharma (NASDAQ: VINC) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Vincerx Pharma's revenue was $0.00.
What was VINC's revenue growth in the past year?
As of Q1 2024, Vincerx Pharma's revenue has grown null year over year. Vincerx Pharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.